glp-1 coverage news Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford 🚨 BIG NEWS FOR MEDICARE

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

Evidence-based guidance on safety, monitoring, and when to discuss treatment with your healthcare team.

Metabolism & Energy: Formulated with ingredients that support metabolic processes and contribute to normal energy-yielding metabolism

Learn what it is, why people are trying it to lower side effects and cost, and how to do it safely, effectively, step by step.

There is increasing concern about the development of pancreatitis in patients with diabetes mellitus who received long-term glucagon-like peptide-1 (GLP-1) analog treatment